News

Opinion
Zacks Investment Research on MSN6dOpinion
Top Research Reports for Visa, ServiceNow & Progressive
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Visa Inc. (V), ServiceNow, Inc. (NOW) ...
BATON ROUGE, La. (AP) — BATON ROUGE, La. (AP) — Amedisys Inc. (AMED) on Wednesday reported first-quarter earnings of $61 million. On a per-share basis, the Baton Rouge, Louisiana-based company said it ...
Amedisys (AMED) came out with quarterly earnings of $1.25 per share, beating the Zacks Consensus Estimate of $1.13 per share. This compares to earnings of $1.03 per share a year ago. These figures ...
BATON ROUGE, La. (AP) — BATON ROUGE, La. (AP) — Amedisys Inc. (AMED) on Wednesday reported first-quarter earnings of $61 million. On a per-share basis, the Baton Rouge, Louisiana-based company ...
(2) Adjusted EBITDA is defined as net income attributable to Amedisys, Inc. before net interest expense, provision for income taxes and depreciation and amortization, excluding certain items as ...
April 23, 2025 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ ... requirements and comply with covenants in debt agreements; business disruptions due to natural or man-made disasters, climate change ...
Amedisys (AMED) reported $594.78 million in revenue for the quarter ended March 2025, representing a year-over-year increase of 4.1%. EPS of $1.25 for the same period compares to $1.03 a year ago.
Amedisys (Nasdaq: AMED) exceeded Wall Street expectations in its first-quarter results for 2025. The company’s home health segment benefited from ...